Powerful insights to help personalize treatment

 

This test is designed to help identify appropriate targeted therapies and clinical trials. The Solid Tumor Panel tests for clinically significant mutations in solid tumor cancers, including

 
   
20+ genes found in 15+ guidelines for solid tumor genetic testing 115+ genes included in 800+ clinical trials worldwide 15+ genes associated with 30+ targeted therapies that are approved by the FDA